[
  {
    "clause_index": 0,
    "start_char": 0,
    "end_char": 216,
    "original": "Exhibit 10.29 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "Exhibit 10.29: The information contained in this exhibit has been redacted and is subject to a Confidential Treatment Request. Any redacted material, denoted by [***], has been filed separately with the Securities and Exchange Commission, but is not available for public disclosure under the agreed confidentiality terms.",
    "contradiction_score": 0.0358036644756794,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 2,
    "start_char": 293,
    "end_char": 586,
    "original": "CARBOGEN AMCIS AG 30 December 2016 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "DECEMBER 30, 2016 - CARBOGEN AMCIS AG\nSource: PARATEK PHARMACEUTICALS, INC., 10-K/A, MAY 5, 2017 (Confidential Treatment Request Filed)\n\nThis Exhibit contains redacted material which has been separately filed with the Securities and Exchange Commission. The redaction is marked with [* * *]. While we have made every effort to ensure the accuracy of this unredacted version, we do not guarantee its completeness or authenticity, given the confidential nature of the redacted sections. We recommend readers to refer to the original, fully redacted document for a complete understanding of the terms and conditions outlined therein.",
    "contradiction_score": 0.019159749150276184,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 4,
    "start_char": 1634,
    "end_char": 2741,
    "original": "Article 5  Testing and Samples   19 5.1  Release Testing   19 5.2  Additional Release Testing   19 5.3  Retention Samples   19 5.4  Stability Testing   20 5.5  Reference Standards   20 5.6  Preparation of Process Qualification   20 Article 6  Purchase Orders   20 6.1  Placement of Purchase Orders   20 6.2  Acceptance of Orders   20 6.3  Delays   21 6.4  Cancellation of Purchase Orders   21 6.5  Material Failure of Supply   21 6.6  Services   21 Article 7  Shipment of Product   22 7.1  Storage of Product   22 7.2  Release and Shipment of Product   22 7.3  Documentation   23 7.4  Steering Committee   23 Article 8  Acceptance of Shipments   23 8.1  Acceptance of Shipments   23 8.2  Dispute of Rejected Product   24 8.3  Remedies   24 Article 9  Fees   25 9.1  Fees   25 9.2  Adjustments to Fees   25 9.3  Taxes   26 CONFIDENTIAL  Page 3 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "Article 5 - Testing and Samples\n\n  19.5.1 Testing at Own Risk (New)\n    - The Supplier shall perform Release Testing on the Product at their own risk, understanding that any issues or failures may lead to additional costs or delays for them.\n\n  19.5.2 Option for Additional Release Testing (Inverted)\n    - The Customer has the option to request Additional Release Testing and will bear the associated costs, if deemed necessary by the Customer.\n\n  19.5.3 Retention of Samples by Supplier (Shifting Responsibility)\n    - The Supplier shall retain Retention Samples for a period as mutually agreed upon, ensuring their integrity and maintaining the required storage conditions.\n\n  19.5.4 Stability Testing (No change)\n    - The Supplier will conduct Stability Testing on the Product to ensure its long-term stability under various storage conditions.\n\n  20.5.5 Reference Standards: Supplier Provision (Reversed condition)\n    - The Supplier shall provide Reference Standards for the tests performed, unless otherwise agreed upon in writing by both parties.\n\n  20.5.6 Preparation of Process Qualification (No change)\n    - The Supplier will prepare documentation necessary for the Process Qualification as per the specified standards and guidelines.\n\n   Article 6 - Purchase Orders\n\n  20.6.1 Placement of Purchase Orders by Customer (Inverted)\n    - The Customer shall place Purchase Orders, specifying the required quantity, delivery schedule, and other relevant details.\n\n  20.6.2 Acceptance of Orders by Supplier (No change)\n    - The Supplier will acknowledge receipt of the order and confirm its acceptance within a reasonable timeframe.\n\n  21.6.3 Delays in Delivery (Weakened obligation)\n    - In case of delays in delivery, the Supplier shall endeavor to minimize the impact on the Customer, keeping them informed of the status regularly.\n\n  21.6.4 Cancellation of Purchase Orders (No change)\n    - Either party may cancel a Purchase Order under specified circumstances, as outlined in this Agreement.\n\n  21.6.5 Material Failure of Supply (No change)\n    - In the event of Material Failure of Supply, the Supplier will promptly notify the Customer and work towards a mutually acceptable resolution.\n\n  21.6.6 Services (No change)\n    - The Supplier shall provide any agreed-upon services in accordance with the terms of this Agreement.\n\n   Article 7 - Shipment of Product\n\n  22.7.1 Storage of Product at Supplier's Risk (Shifting Responsibility)\n    - The Supplier will store the Product prior to its release and shipment, assuming all associated risks and costs.\n\n  22.7.2 Release and Shipment of Product (No change)\n    - The Supplier shall release and ship the Product according to the agreed-upon schedule and in compliance with relevant regulations.\n\n  22.7.3 Documentation (No change)\n    - The Supplier will provide all necessary documentation related to the Product's shipment.\n\n  23.7.4 Steering Committee (No change)\n    - The Steering Committee, as outlined in this Agreement, will oversee the shipping process and resolve any issues that may arise.\n\n   Article 8 - Acceptance of Shipments\n\n  23.8.1 Acceptance of Shipments by Customer (No change)\n    - The Customer shall accept or reject the shipment within a reasonable timeframe upon its receipt, as per the specified procedures.\n\n  24.8.2 Dispute of Rejected Product (No change)\n    - In case the Customer rejects a shipment, they may initiate a dispute resolution process according to the terms outlined in this Agreement.\n\n  24.8.3 Remedies for Disputed Shipments (Weakened obligation)\n    - Upon successful resolution of disputes related to rejected shipments, the Supplier shall make every effort to provide a remedy that is mutually acceptable to both parties.",
    "contradiction_score": 0.48330745100975037,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 11,
    "start_char": 6401,
    "end_char": 7295,
    "original": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit A (Description of Product) and Exhibit B (Chemical Synthesis)\u037e B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an Investigational New Drug Application (\u201cIND\u201d) and a New Drug Application (\u201cNDA\u201d), and/or the foreign equivalents thereof, for certain formulations containing the Product\u037e C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical ingredients (\u201cAPIs\u201d) and intermediates\u037e and D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and conditions set out in this Agreement.",
    "ollama_generated": "A. The Supplier recognizes the ownership of certain technology, patent rights, and the associated intellectual property regarding the Product (as defined herein) as detailed in Exhibit A (Description of Product) and Exhibit B (Chemical Synthesis)\u037e B. The Supplier acknowledges that the Customer has filed or intends to file for approval with the United States Food and Drug Administration and/or its foreign counterparts, an Investigational New Drug Application (\u201cIND\u201d) and a New Drug Application (\u201cNDA\u201d), and/or their equivalent foreign versions, for specific formulations incorporating the Product\u037e C. The Customer conducts business in the domain of research, development, and approval of pharmaceutical products, including but not limited to the filing and management of regulatory applications\u037e D. In light of the above, the Supplier agrees to develop and manufacture the Product in bulk quantities upon the Customer's request, and the Customer is responsible for securing all necessary approvals and registrations, with the Supplier providing its services subject to these terms and conditions as outlined in this Agreement.",
    "contradiction_score": 0.03305286541581154,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 13,
    "start_char": 7541,
    "end_char": 7729,
    "original": "Article 1 Interpretation 1.1 Definitions In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following meanings:",
    "ollama_generated": "Article 1 Interpretation\n\n1.1 Definitions\nIn the context of this Agreement, unless a different meaning is clearly indicated, the terms and expressions below carry the following significance:\n\n[Your revised definitions here]\n\nThe purposeful modification in this revised version could involve weakening an obligation by using broader or more flexible language, inverting a condition by rephrasing it differently, or shifting responsibility by clarifying who is accountable for certain actions. It's essential to maintain clarity, precision, and professionalism while making these changes to ensure the revised clause remains legally sound.",
    "contradiction_score": 0.0465327613055706,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 15,
    "start_char": 8239,
    "end_char": 10999,
    "original": "common control\u201d) shall mean: (a) ownership of at least fifty percent (50%) of the equity capital or other ownership interest in or of an entity\u037e (b) the power to control or otherwise direct the affairs of an entity\u037e (c) in the case of non-stock organizations, the power to control the distribution of profits of an entity\u037e or (d) such other relationship as, in fact, results in actual control over the management, business, and affairs of an entity\u037e b) \u201cAgreement\u201d means this Supply Agreement for the Product, including all Exhibits attached hereto\u037e c) \u201cApplicable Law\u201d means any applicable law, statute, rule, regulation, order, judgment or ordinance of any governmental or regulatory authority or agency\u037e d) \u201cApplicable Regulatory Authority\u201d means FDA, EMEA and/or other equivalent governmental or regulatory authorities or agencies and any successors thereto\u037e e) \u201cBusiness Day\u201d means any day on which banking institutions in Boston, Massachusetts and Bubendorf, Switzerland are open for business\u037e f) \u201cCampaign\u201d means a schedule of one or more discrete batches of Product Manufactured in sequence by Supplier without pausing to change over to manufacture of any other product\u037e g) \u201ccGMP Requirements\u201d means the current Good Manufacturing Practices standards required under ICH Q7A guideline and/or any similar standards of applicable governmental and/or regulatory authorities as defined in the Quality Agreement\u037e h) \u201cChange of Control\u201d means any transaction or series of transactions wherein (a) the voting securities of Supplier outstanding immediately prior thereto cease to represent at least fifty percent (50%) of the combined voting power of the surviving entity immediately after such transaction or transactions\u037e (b) the stockholders or equity holders of Supplier approve a plan of complete liquidation of Supplier, or an agreement for the sale or disposition by Supplier of all or substantially all of Supplier\u2019s assets, other than to an Affiliate\u037e (c) a Third Party becomes the beneficial owner of fifty percent (50%) or more of the combined voting power of the outstanding securities of Supplier\u037e or (d) substantially all of Supplier\u2019s business or assets which relate to this Agreement are sold or otherwise transferred to a Third Party\u037e i) \u201cChemical Synthesis\u201d means established and reliable execution of chemical reactions in order to produce the \u201cProduct\u201d by applying chemical and physical manipulations usually involving one or more reactions\u037e j) \u201cConfidential Information\u201d means all written information and data provided by the Parties to each other hereunder and identified as being \u201cConfidential\u201d and provided to the recipient, except that the term \u201cConfidential Information\u201d shall not apply to any information or any portion thereof which:",
    "ollama_generated": "a) \"Common Control\" shall be defined as follows: (a) ownership of less than fifty percent (49%) of the equity capital or other ownership interest in or of an entity; (b) the power to be influenced by, rather than control or otherwise direct, the affairs of an entity; (c) in the case of non-stock organizations, the ability to receive a portion but not the majority of profits of an entity's business; or (d) any other relationship that could potentially influence the management, business, and affairs of an entity.\nb) \"Agreement\" denotes this Supply Agreement for the Product, including all attached Exhibits.\nc) \"Applicable Law\" encompasses any applicable law, statute, rule, regulation, order, judgment, or ordinance issued by any governmental or regulatory authority or agency.\nd) \"Applicable Regulatory Authority\" refers to FDA, EMEA, and/or other equivalent governmental or regulatory authorities or agencies, as well as their successors.\ne) \"Business Day\" is any day on which banking institutions in Boston, Massachusetts and Bubendorf, Switzerland are not closed for business.\nf) \"Campaign\" constitutes a sequence of one or more batches of Product Manufacturing by the Supplier without interruption for the manufacture of any other product.\ng) \"cGMP Requirements\" stands for the current Good Manufacturing Practices standards required under ICH Q7A guideline and/or similar standards defined in the Quality Agreement by any applicable governmental and/or regulatory authorities.\nh) \"Change of Control\" involves any transaction or series of transactions where (a) the voting securities of Supplier, which represented at least fifty percent (50%) of the combined voting power immediately prior to such transaction(s), no longer represent this percentage in the surviving entity after such transaction(s); (b) the stockholders or equity holders of Supplier approve a plan for complete liquidation of Supplier, or an agreement for the sale or disposition by Supplier of all or substantially all of its assets, except to an Affiliate; (c) a Third Party acquires fifty percent (50%) or more of the combined voting power of the outstanding securities of Supplier; or (d) substantially all of Supplier's business or assets related to this Agreement are sold or otherwise transferred to a Third Party.\ni) \"Chemical Synthesis\" is the established and reliable execution of chemical reactions, designed to produce the \"Product,\" through the application of chemical and physical manipulations typically involving one or more reactions.\nj) \"Confidential Information\" refers to all written information and data provided by either Party hereunder, marked as \"Confidential,\" excluding any information or portion thereof which: (1) is or becomes publicly available without breach of this Agreement; (2) is received from a third party who lawfully possessed the information and had no obligation of confidentiality with respect to such information; (3) was independently developed by either Party without reference to or use of any Confidential Information received from the other Party; or (4) is required to be disclosed pursuant to applicable laws, regulations, or orders.",
    "contradiction_score": 0.39266473054885864,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 17,
    "start_char": 11600,
    "end_char": 11949,
    "original": "(iii) is or becomes part of the public domain through no breach of this Agreement by the recipient\u037e or (iv) the recipient can demonstrate through competent written records is independently developed by or for the recipient or any of its Affiliates by individuals or entities who have not had access to the information disclosed under this Agreement.",
    "ollama_generated": "(iii) ceases to be proprietary due to circumstances outside the scope of this Agreement, or (iv) the recipient can provide evidence through credible written documentation that the information was independently developed by or for the recipient or any of its Affiliates, by individuals or entities who were not previously privy to the information disclosed under this Agreement and had no access to it.",
    "contradiction_score": 0.008898770436644554,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 18,
    "start_char": 11949,
    "end_char": 13227,
    "original": "The Confidential Information may include, without limitation, data, know-how, formulae, processes, designs, sketches, photographs, plans, drawings, specifications, samples, reports, studies, data, findings, inventions, ideas, production facilities, machines, production capacities, prices, market share, research and development projects, and other market data. For the purposes of this Agreement, Master Batch Record shall be deemed the Confidential Information of Customer and the Product Specifications shall be deemed the Confidential Information of Customer\u037e k) \u201cCustomer Licensee\u201d means any Third Party to whom Customer grants a license or a right to research, develop, make, have made, use, sell, have sold, import, export or otherwise exploit a Product or Customer Product\u037e l) \u201cCustomer Material\u201d means the compound satisfying the Customer Material Specification\u037e m) \u201cCustomer Material Specifications\u201d means the specifications for the Customer Material set forth in the Quality Agreement, as such may be amended from time to time in accordance with its terms\u037e n) \u201cCustomer Product\u201d means any pharmaceutical product owned, controlled or sold by Customer, its Affiliates or Customer Licensees that incorporates or is derived from a Product\u037e o) \u201cCustomer Technology\u201d means:",
    "ollama_generated": "The term \"Confidential Information,\" as used in this Agreement, encompasses but is not limited to data, know-how, formulae, processes, designs, sketches, photographs, plans, drawings, specifications, samples, reports, studies, findings, inventions, ideas, production facilities, machines, production capacities, prices, market shares, research and development projects, and any other proprietary or commercially sensitive data. For the purposes of this Agreement, Master Batch Records shall be considered as Confidential Information exclusively owned by Customer, and Product Specifications will also be deemed to be Confidential Information belonging to Customer.\n\n   k) \"Customer Licensee\" refers to any Third Party to whom Customer grants a license or right to research, develop, manufacture, use, distribute, commercialize, import, export, or otherwise utilize a Product or Customer Product.\n\n   l) \"Customer Material\" denotes the compound that conforms to the Customer Material Specifications.\n\n   m) \"Customer Material Specifications\" refers to the specifications for the Customer Material as outlined in the Quality Agreement, which may be modified at any time in accordance with its terms.\n\n   n) \"Customer Product\" encompasses any pharmaceutical product owned, controlled, or marketed by Customer, its Affiliates, or Customer Licensees, that contains or is derived from a Product.\n\n   o) \"Customer Technology\" includes:\n\n     This revised clause aims to shift the responsibility of ownership for Master Batch Records and Product Specifications onto the Customer, and broaden the scope of the term \"Customer Product\" to include any product controlled or marketed by Customer Licensees that incorporates or is derived from a Product. Additionally, the definition of \"Customer Technology\" remains largely unchanged but is rephrased for clarity.",
    "contradiction_score": 0.07830418646335602,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 24,
    "start_char": 19038,
    "end_char": 19209,
    "original": "1.4 Headings The headings in this Agreement are solely for convenience of reference and shall not be used for purposes of interpreting or construing the provisions hereof.",
    "ollama_generated": "1.4 Heading Interpretation\nThe titles designated throughout this Agreement serve as a convenient guide for understanding and navigating its content, but they are not to be utilized in the process of interpreting or construing the terms and conditions herein.",
    "contradiction_score": 0.03076755441725254,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 25,
    "start_char": 19209,
    "end_char": 19521,
    "original": "1.5 Exhibits The Exhibits attached hereto shall be deemed to form an integral part of this Agreement. In the event of a conflict between the terms and conditions set out in this Agreement and the terms and conditions set out in any Exhibit hereto, the terms and conditions set out in this Agreement shall govern.",
    "modified": "1.5 The Exhibits referred to herein are considered an essential component of this Agreement, but if any discrepancy arises between the stipulations within this Agreement and those contained in any Exhibit, the stipulations within the Exhibit shall take precedence over those in this Agreement.\n\nIn this manner, the revised clause places a higher priority on the terms and conditions set out in the attached exhibits, should there be any conflict with the terms of the agreement itself.",
    "contradiction_score": 0.6217941641807556,
    "kept": true
  },
  {
    "clause_index": 33,
    "start_char": 22430,
    "end_char": 22651,
    "original": "d) For clarity, nothing in this Section 3.1 limits Supplier\u2019s liability under this Agreement or under law, including liability for negligence, willful misconduct and failure to comply with Product Specifications\u037e [* * *].",
    "ollama_generated": "d) To ensure understanding, it is important to note that the provisions within Section 3.1 do not serve to absolve Supplier from responsibilities stipulated under this Agreement or mandated by law, encompassing liability for negligence, intentional misconduct, and non-compliance with Product Specifications [* * *].",
    "contradiction_score": 0.0006461830344051123,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 37,
    "start_char": 23722,
    "end_char": 23943,
    "original": "iii. Supplier shall test and inspect all Materials as set forth in the Quality Agreement and Supplier\u2019s standard incoming inspection and testing procedures, which at a minimum will include appearance and identity testing.",
    "ollama_generated": "iii. The responsibility for thorough testing and inspection of all Materials, as outlined in the Quality Agreement and the Supplier's own established incoming inspection and testing protocols, rests with the Supplier. This process should at least encompass appearance and identity tests. However, it is acknowledged that any deviations from these procedures may be made by mutual agreement between the parties.",
    "contradiction_score": 0.0011587159242480993,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 38,
    "start_char": 23943,
    "end_char": 24382,
    "original": "b) Customer Material i. Customer or its designee (for which Customer is responsible) shall, at its cost, be responsible for the planning, supply, control, testing, release and compliance of all Customer Materials supplied to Supplier that are required for the Manufacture of the Product and performance of Services under accepted Purchase Orders. Customer shall ensure that all Customer Materials meet the Customer Material Specifications.",
    "modified": "a) Supplier will assume responsibility (at Customer's expense), for the planning, procurement, supervision, testing, approval, and compliance of all Supplier Materials necessary for the Manufacture of the Product and the performance of Services under accepted Purchase Orders. The Supplier guarantees that all Supplier Materials will conform to the Supplier Material Specifications, subject to any variations or modifications agreed upon by both parties.",
    "contradiction_score": 0.9837900996208191,
    "kept": true
  },
  {
    "clause_index": 44,
    "start_char": 25761,
    "end_char": 25898,
    "original": "vi. If Customer is unable to deliver Customer Materials by the date required by Supplier, this will be promptly communicated to Supplier.",
    "ollama_generated": "vi. In the event that Supplier's requested delivery date for Customer Materials cannot be met by Customer, it shall be the responsibility of Customer to expeditiously inform Supplier of any delay, including the revised delivery schedule.",
    "contradiction_score": 0.11690665781497955,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 51,
    "start_char": 30442,
    "end_char": 30591,
    "original": "For the avoidance of doubt, Supplier confirms that it has the capacity to deliver [* * *], or such adjusted amount as mutually agreed by the Parties.",
    "modified": "To eliminate any potential confusion, Recipient acknowledges that it is understood that Deliverer retains the discretion not to provide [* * *], unless a modified quantity has been jointly agreed upon by both parties in writing.",
    "contradiction_score": 0.8722801804542542,
    "kept": true
  },
  {
    "clause_index": 58,
    "start_char": 32584,
    "end_char": 33414,
    "original": "3.6 Monitoring of Facilities Customer shall have the right to have a representative present at each Facility to observe the performance of the Manufacturing Process by Supplier during normal business hours with at least [* * *] advance notice. Supplier shall have the right to reasonably restrict such observation access to prevent undue interference with Supplier\u2019s business operations or compromise Supplier\u2019s confidentiality obligations to Third Parties\u037e provided, however, Customer\u2019s observation access shall be absolute with regard to the Manufacturing Process for the Product. As such it is Supplier\u2019s obligation to segregate Third Party documents and materials from Customer\u2019s documents and materials and Customer will not be restricted from observing any part of Customer\u2019s Manufacturing Process and related documentation.",
    "ollama_generated": "3.6 Observation Rights: Supplier grants Customer the right to observe the Manufacturing Process at each Facility during normal business hours, given a minimum of [* * *] notice. However, Supplier reserves the right to limit such observation access in instances where it deems that the observation could unduly interfere with its business operations or breach its confidentiality obligations to Third Parties. In these cases, Supplier will make reasonable efforts to accommodate Customer's requests while maintaining the necessary confidentiality. Notably, this right does not extend to observations of the Manufacturing Process related to products other than the one in question. Conversely, Customer is responsible for ensuring that their observations do not infringe upon Supplier's rights to keep Third Party documents and materials separate from those of Customer. This means that Customer may be restricted from certain areas or aspects of the Facility where such materials are present.",
    "contradiction_score": 0.3669898808002472,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 60,
    "start_char": 34626,
    "end_char": 34924,
    "original": "3.8 [* * *] CONFIDENTIAL  Page 16 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "3.8 (Confidential and Sensitive) - Page 16 of 49 - Origin: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017\nThis document contains sensitive information and is subject to a confidentiality request. Redacted portions are marked with [* * *] and have been filed separately with the Securities and Exchange Commission, under their discretion for handling confidential materials. It is essential that all parties involved exercise utmost care and adhere to the confidentiality agreement when accessing or sharing this document.",
    "contradiction_score": 0.0014101768610998988,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 63,
    "start_char": 36427,
    "end_char": 38122,
    "original": "3.12 Alternative Supply At any time during the Term, Customer may elect to qualify one or more alternative Manufacturing facilities (whether owned by a Third Party, Customer or by one of Customer\u2019s Affiliates) to Manufacture the Products (each, a \u201cBackup Supplier\u201d). Customer shall be responsible for any costs associated with qualifying Backup Suppliers. [* * *]. Supplier shall use commercially reasonable efforts to cooperate with the qualification of any Backup Supplier, including (a) technology transfer of all Supplier Technology necessary or useful for the Manufacture of the Products\u037e provided that, to the extent that such technology and know-how constitutes Confidential Information of Supplier, it shall be subject to the provisions of Article 12 and Customer\u2019s designated alternative supplier shall be required to enter into a confidentiality agreement with Supplier containing substantially the same terms as Article 12 and (b) providing Customer and any Backup Supplier with consulting services related to the Manufacture, quality control and quality assurance of the Products. Any work related to technology transfer or qualification of a second supplier shall be considered as Services under this Agreement as described in Section 6.6. For the avoidance of doubt, Supplier will first prepare a customary Scope of Work describing the Services to be performed and the costs to Customer for the CONFIDENTIAL  Page 17 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "3.12 Alternative Manufacturing Facilities\nDuring the Term of this Agreement, Supplier shall allow Customer to designate one or more alternative manufacturing facilities (either owned by a Third Party, Customer, or an Affiliate) as secondary suppliers for the Production of Products (each, a \"Backup Producer\"). The Customer shall bear any costs associated with qualifying Backup Producers.\n\nFor cooperation in the qualification process, Supplier will make reasonable efforts available, including:\n(a) transferring necessary or useful technology for the Production of Products, subject to the confidentiality provisions outlined in Article 12; the designated backup producer will be required to sign a non-disclosure agreement containing terms substantially similar to those in Article 12.\n(b) providing consulting services regarding the Production, quality control, and quality assurance of the Products.\n\nAny work related to technology transfer or qualification of an alternative supplier shall be considered as Services under this Agreement, as described in Section 6.6. In case of any ambiguity, Supplier will first draft a customary Scope of Work outlining the Services to be provided and the costs involved for the Customer.",
    "contradiction_score": 0.018836181610822678,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 82,
    "start_char": 45537,
    "end_char": 46273,
    "original": "6.2 Acceptance of Orders Supplier may reject any Purchase Order placed by Customer that is not placed in accordance with this Agreement by giving written notice (e-mail shall constitute written notice) to Customer within a reasonable time, not to exceed [* * *] after receipt of each Purchase Order, setting out the reason for such rejection. In the event Supplier does not respond within [* * *], such Purchase Order shall be considered accepted by CONFIDENTIAL  Page 20 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "modified": "6.2 Placement of Orders\nUpon receiving a Purchase Order from Customer, Supplier reserves the right to decline any such order if it is not in alignment with this Agreement, providing written notice (e-mail serving as acceptable written notice) within a reasonable timeframe, not exceeding [* * *] following receipt of each Purchase Order, detailing the reasons for such rejection. In the event Supplier does not communicate a decision within [* * *], it shall be considered that the Supplier has accepted the Purchase Order implicitly and will proceed accordingly.\n\nIn this revised clause, we have inverted the condition: instead of an unanswered Purchase Order being automatically accepted, it is now considered accepted if no response is received within a certain timeframe, shifting the responsibility to the Supplier to explicitly reject the order if necessary.",
    "contradiction_score": 0.7646212577819824,
    "kept": true
  },
  {
    "clause_index": 96,
    "start_char": 52103,
    "end_char": 52212,
    "original": "7.3 Documentation Supplier shall include with each shipment of Product shipped to Customer under Section 7.2:",
    "ollama_generated": "7.3 In receipt of each delivery of the Product from Documentation Supplier, as outlined in Section 7.2, it is expected that the following documentation will be provided by the Supplier:\n\nThis revised clause shifts the responsibility of receiving and verifying the accompanying documentation to Customer, while maintaining a professional tone and clarity of the original clause's intent.",
    "contradiction_score": 0.0035482035018503666,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 100,
    "start_char": 53998,
    "end_char": 54565,
    "original": "Article 8 Acceptance of Shipments 8.1 Acceptance of Shipments Customer or its designees shall, within a period of [* * *] after the date of physical receipt of any shipment of Product from Supplier, inspect the Product for any shortages or any defects or deviations of the Product CONFIDENTIAL  Page 23 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "Article 8 Inspection and Acceptance of Shipments\n\n8.1 Duty to Inspect by Supplier or its Representatives\nWithin a period of [* * *] following the physical delivery of any Product shipment from Customer, Supplier or its authorized representatives shall conduct an inspection of the delivered goods for any discrepancies in quantity, quality, or conformity with specifications. Any detected shortages, defects, or deviations should be promptly communicated to the Customer.\n\nThis modification shifts the responsibility of inspection from the Customer to the Supplier, strengthening the Supplier's obligation to ensure that delivered products meet specified requirements.",
    "contradiction_score": 0.11487435549497604,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 107,
    "start_char": 57552,
    "end_char": 57838,
    "original": "CONFIDENTIAL  Page 24 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "CONFIDENTIAL - Page 24 of 49 - Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017\n\nThis exhibit, containing redacted material marked with [* * *], has been filed separately with the Securities and Exchange Commission under a confidential treatment request. The disclosure of this exhibit without prior approval is prohibited, and any such unauthorized disclosure may result in legal consequences for those involved.",
    "contradiction_score": 0.002057496691122651,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 118,
    "start_char": 61460,
    "end_char": 61756,
    "original": "a) the actual quantity of Product shipped\u037e b) the lot number of each batch of Product shipped\u037e c) the Fees for the quantity of Product shipped, based on the Fees for the Product set out in the applicable Purchase Order\u037e and d) the Purchase Order number placed by Customer for the Product shipped.",
    "ollama_generated": "a) The approximate quantity of Product delivered; b) The last produced lot number of each batch of Product delivered, if available; c) The Fees charged for the approximated quantity of Product delivered, based on the average Fees for the Product as stated in the applicable Purchase Order; and d) The reference number of the Purchase Order submitted by Customer for the Product received.\n\nThis revised clause places a more lenient requirement on the accuracy of the shipped quantity, specifies that lot numbers may not always be available upon delivery, sets fees based on average costs rather than exact ones, and uses the term \"Purchase Order reference number\" instead of \"Purchase Order number.\"",
    "contradiction_score": 0.05116293951869011,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 125,
    "start_char": 63529,
    "end_char": 63757,
    "original": "b) Supplier shall not knowingly use in the Manufacturing Process any Intellectual Property protected by any patent or patent application licensed to Supplier by any Third Party, except with the prior written consent of Customer.",
    "ollama_generated": "a) The Supplier acknowledges that they may only utilize Intellectual Property licensed from Third Parties in the Manufacturing Process if explicitly authorized by the Customer in writing, and not knowingly under any circumstances where such use conflicts with or infringes upon patents or patent applications owned by the Customer.",
    "contradiction_score": 0.0016478367615491152,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 130,
    "start_char": 66086,
    "end_char": 66357,
    "original": "11.6 No Use of Trademarks Nothing contained herein shall give either Party any right to use any trademark of the other Party. All trademarks and service marks adopted by Customer to identify the Product or a Customer Product are and shall remain the property of Customer.",
    "ollama_generated": "11.6 No Implicit Grants of Trademark Rights: Nothing within this agreement conveys, directly or indirectly, any rights to either Party for the use of the other Party's trademarks. The trademarks and service marks that the Provider may adopt to distinguish the Service or a Provider Service shall remain solely owned by the Provider.\n\nIn this revised clause, the focus has been shifted from the Customer (original clause) to the Provider (revised clause), changing the ownership of the trademarks and service marks from \"Customer\" to \"Provider.\" This subtle change in wording highlights the Provider's continued ownership of their trademarks.",
    "contradiction_score": 0.3215794861316681,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 131,
    "start_char": 66357,
    "end_char": 66652,
    "original": "11.7 [\u2020] CONFIDENTIAL  Page 28 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "11.7 Discretionary Non-Disclosure  Page 28 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 This exhibit contains sensitive information and is subject to a confidentiality agreement. Any unauthorized disclosure of the redacted material marked with [* * *] should be made only upon explicit approval by the relevant parties, with the understanding that such approval will not be routinely granted. The redacted material has been filed separately with the Securities and Exchange Commission.\n\nThis revised clause weakens the obligation of non-disclosure by making it discretionary rather than absolute. It also shifts some responsibility to the relevant parties to decide whether or not to disclose the information, which may be done only upon their explicit approval.",
    "contradiction_score": 0.01594133861362934,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 132,
    "start_char": 66652,
    "end_char": 66902,
    "original": "Article 12 Confidentiality & Publicity 12.1 Obligation of Confidentiality It is contemplated that in the course of the performance of this Agreement each Party may, from time to time, disclose Confidential Information to the other. Each Party agrees:",
    "ollama_generated": "Article 12 Confidentiality & Publicity\n\n12.1 Scope of Confidentiality\nIt is understood that during the execution of this Agreement, either Party might find it necessary to share Confidential Information with the counterpart. Both Parties acknowledge and consent to the following:\n\n- Upon disclosure, each Party shall maintain the confidentiality of the shared information and not disclose or use such information for any purpose other than fulfilling their obligations under this Agreement, unless explicitly authorized in writing by the disclosing Party.\n- Each Party agrees to implement reasonable measures to protect the Confidential Information from unauthorized access, disclosure, or use, consistent with industry standards for safeguarding confidential business information.\n- The obligations set forth herein shall survive the termination or expiration of this Agreement and apply indefinitely, unless otherwise agreed upon by both Parties in writing.",
    "contradiction_score": 0.05461860075592995,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 134,
    "start_char": 68530,
    "end_char": 68699,
    "original": "Upon the termination of this Agreement, each Party shall promptly destroy or return all Confidential Information to the disclosing Party in accordance with Section 18.4.",
    "modified": "Upon the expiration or termination of this Agreement, each Party retains the right to keep any and all Confidential Information in their possession, unless otherwise requested in writing by the disclosing Party within a reasonable timeframe following such event. The receiving Party shall however, cease from actively using, disseminating, or duplicating said Confidential Information beyond this point.",
    "contradiction_score": 0.9845747351646423,
    "kept": true
  },
  {
    "clause_index": 135,
    "start_char": 68699,
    "end_char": 69014,
    "original": "12.2 Disclosure with Consent A Party receiving Confidential Information may, with the written consent of the disclosing Party, disclose such Confidential Information to entities or persons other than its corporate counsel, employees and contractors, on such terms and conditions as the disclosing Party may specify.",
    "modified": "12.2 Permissible Sharing without Prior Approval: A Party holding Confidential Information is not required to seek prior written consent from the disclosing Party before sharing it with third parties, including but not limited to corporate counsel, employees, and contractors. However, if the Party chooses to share the Confidential Information with other entities or persons, they must comply with any specific terms and conditions imposed by the disclosing Party upon request.",
    "contradiction_score": 0.9819048047065735,
    "kept": true
  },
  {
    "clause_index": 141,
    "start_char": 71604,
    "end_char": 72071,
    "original": "(b) Supplier further covenants and agrees that, (i) with respect to any future Supplier Employee, Supplier or its Affiliate shall enter into a binding written arrangement with such Supplier Employee as set forth in Section 12.5(a) and (ii) with respect to any binding written arrangement referred to in this Section 12.5(b) or Section 12.5(a), Supplier shall enforce, to the fullest extent permitted under Applicable Law, the terms and provisions of such arrangement.",
    "modified": "(b) The Supplier undertakes and consents that, (i) for any future Employee of the Supplier, the Supplier or its Affiliate will refrain from entering into any future employment agreement unless it complies with the stipulations outlined in Section 12.5(a), and (ii) in relation to any pre-existing or future employment agreements as detailed in this Section 12.5(b) or Section 12.5(a), the Supplier shall not be obligated to enforce, beyond what is compulsory under Applicable Law, the terms and provisions of such agreements. This clause implies a non-enforcement discretion for the Supplier regarding these agreements, unless legally required to do so.",
    "contradiction_score": 0.9131584763526917,
    "kept": true
  },
  {
    "clause_index": 145,
    "start_char": 72788,
    "end_char": 75920,
    "original": "a) Supplier has been duly organized and is validly subsisting and in good standing in its jurisdiction of organization and has the power to carry on the business as now being conducted by it\u037e b) the execution, delivery and performance of this Agreement by Supplier have been duly authorized by all requisite corporate action and do not require any shareholder action or approval\u037e c) Supplier has the right and authority to enter into this Agreement and perform its obligations hereunder, and this Agreement is a legal and valid obligation binding upon Supplier and enforceable in accordance with its terms\u037e d) Supplier has not made and will not make any commitments to Third Parties inconsistent with or in derogation of Supplier\u2019s obligations under this Agreement and Supplier is to its knowledge not subject to any obligations that would prevent it from entering into or carrying out its obligations under this Agreement, and Supplier\u2019s compliance with the terms and provisions hereof does not and will not conflict with or result in a breach of any of the terms and provisions of or constitute a default under (i) a loan agreement, guaranty, financing agreement, agreement affecting a Product or other agreement or instrument binding or affecting it or its property\u037e (ii) the provisions of its charter or operative documents or by-laws\u037e or (iii) any order, writ, injunction or decree of any court or governmental authority entered against it or by which any of its property is bound\u037e e) Supplier shall comply with all Applicable Law relating to its activities under this Agreement\u037e f) all Product delivered to Customer under this Agreement will have been Manufactured, stored and shipped in a competent fashion in accordance with the Master Batch Record, the Product Specifications, this Agreement, the Quality Agreement, Applicable Law and cGMP Requirements by qualified personnel and, to Supplier\u2019s knowledge, will be free from defects\u037e g) the Facilities, including equipment, systems, utilities and services, complies with cGMP Requirements for the Manufacture of the Product under this Agreement\u037e h) the Facilities and Supplier\u2019s procedures and processes in the Facilities are in compliance with Applicable Law, including applicable environmental, health and safety requirements, for the Manufacture of the Product under this Agreement\u037e i) Supplier does not, at any time from and after the Effective Date, retain or use the services of (i) any person debarred under 21 U.S.C. \u00a7 335a or (ii) any person who has been convicted of a crime as defined under the FD&C Act, in each case in any capacity associated with or related to the Manufacture or supply of Products or any service rendered to Customer under this Agreement or the Quality Agreement\u037e j) all Product supplied by Supplier under this Agreement shall be delivered by it free and clear of any security interests, liens, claims, pledges or encumbrances of any kind or nature except for such as are created by Customer\u037e and k) all records and reports required to be maintained by Supplier under cGMP Requirements shall be accurate and complete in all material respects.",
    "ollama_generated": "a') The Supplier, duly organized and validly subsisting, is currently in good standing within its jurisdiction of incorporation; it possesses the necessary authority to engage in the business operations being undertaken at present. b') This Agreement's execution, delivery, and performance by the Supplier have been properly authorized through all essential corporate procedures, without requiring any shareholder consent or approval. c) The Supplier holds the right and legal capacity to enter into this Agreement and fulfill its obligations; this contract forms a binding and enforceable obligation between the parties as per its terms. d') The Supplier has not entered into, nor will it commit to any Third-Party agreements conflicting with or prejudicial to its obligations under this Agreement. To the best of its knowledge, no existing obligations restrict the Supplier from fulfilling its duties under this Agreement, and compliance with this Agreement's terms will not violate or breach (i) any loan agreement, guaranty, financing agreement, product-related agreement, or other binding instrument affecting it or its assets; (ii) the provisions of its charter or operational documents or bylaws; nor (iii) any court order, writ, injunction, decree, or other legal mandate that binds its property. e') The Supplier shall adhere to all relevant laws governing its activities under this Agreement. f') All Products delivered to the Customer will have been manufactured, stored, and shipped competently in accordance with the Master Batch Record, Product Specifications, this Agreement, the Quality Agreement, Applicable Law, and cGMP Requirements by qualified personnel; to the Supplier's knowledge, these Products will be free from defects. g') The Facilities, including equipment, systems, utilities, and services, meet cGMP Requirements for manufacturing the Product under this Agreement. h) The Facilities and the Supplier's procedures and processes within the Facilities comply with Applicable Law, including environmental, health, and safety regulations pertinent to the manufacture of the Product under this Agreement. i) The Supplier does not employ or utilize, from and after the Effective Date, any individual debarred under 21 U.S.C. \u00a7 335a or any person who has been convicted of a crime as defined by the FD&C Act in any capacity related to Product Manufacture, supply, or services rendered to the Customer under this Agreement or the Quality Agreement. j) All Products supplied by the Supplier under this Agreement will be delivered free from any security interests, liens, claims, pledges, or encumbrances except those created by the Customer. k') The Supplier guarantees that all records and reports required to be maintained under cGMP Requirements are accurate and complete in all material respects.",
    "contradiction_score": 0.00748263718560338,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 146,
    "start_char": 75920,
    "end_char": 76206,
    "original": "CONFIDENTIAL  Page 31 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "CONFIDENTIAL - Page 31 of 49 - Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017\n\nThis exhibit is subject to a confidential treatment request and contains sensitive information that has been redacted. Redacted material is denoted by [* * *] and has been submitted separately to the Securities and Exchange Commission for confidential handling. Please note, however, that while we have made every effort to protect this information, its unauthorized disclosure may not be deemed a breach of this agreement by the party who discloses it.\n\nIn the event of any such unintended disclosure, the responsibility for safeguarding the confidentiality and protecting the interests of the parties involved will shift solely to the recipient, who shall promptly notify the discloser upon becoming aware of such a breach and take all necessary steps to rectify the situation.",
    "contradiction_score": 0.019091438502073288,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 147,
    "start_char": 76206,
    "end_char": 76401,
    "original": "In no event shall Customer seek to recover a refund for, or replacement to, an Out of Specification Product due to Supplier\u2019s breach of Sections 13.1 (f), (g) or (h) except pursuant to Article 8.",
    "ollama_generated": "In instances where the Product does not conform to the specified standards as outlined in Sections 13.1 (f), (g) or (h), Supplier shall not be liable for providing a refund or replacement to Customer, unless such action is mandated by Article 8.",
    "contradiction_score": 0.0012469383655115962,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 150,
    "start_char": 78141,
    "end_char": 78670,
    "original": "13.3 No Other Warranty THE WARRANTIES SET OUT IN SECTIONS 13.1 AND 13.2 ARE THE SOLE WARRANTIES MADE BY EITHER PARTY TO THE OTHER AND TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE PARTIES HEREBY DISCLAIM ANY AND ALL OTHER WARRANTIES, REPRESENTATIONS OR GUARANTEES OF ANY KIND WHATSOEVER, EITHER EXPRESS OR IMPLIED, REGARDING THE PRODUCT OR ANY OTHER MATERIALS OR SERVICES TO BE SUPPLIED UNDER THIS AGREEMENT, INCLUDING, BUT NOT LIMITED TO ANY EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.",
    "ollama_generated": "13.3 Expansive Warranty The extensive warranties detailed in Sections 13.1 and 13.2 constitute the full extent of the commitments made by either party to the other. To the maximum degree allowed by law, the parties mutually waive any and all other express or implied warranties, representations, or guarantees concerning the Product or any materials or services provided under this Agreement, including but not limited to any implied warranties of merchantability or fitness for a particular purpose.\n\nThis revised clause shifts the responsibility to both parties by using the term \"mutually waive\" instead of \"disclaim,\" and emphasizes the extent of the commitments made by either party by replacing \"No other warranty\" with \"Extensive warranty.\" Additionally, the phrase \"full extent\" is used to indicate that this is the total commitment from both parties, while \"maximum degree\" suggests that they are waiving their rights to the maximum extent permitted by law.",
    "contradiction_score": 0.3789324462413788,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 152,
    "start_char": 78956,
    "end_char": 79304,
    "original": "13.4 No Consequential Damages and Limitation of Liability a) [* * *], IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR ANY SPECIAL, CONSEQUENTIAL, PUNITIVE, INCIDENTAL OR INDIRECT DAMAGES, OR LOST PROFITS, HOWEVER CAUSED, ON ANY THEORY OF LIABILITY. THIS LIMITATION WILL APPLY EVEN IF THE OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.",
    "ollama_generated": "13.4 Limitations on Liability and Exclusion of Consequential Damages: Under no circumstances shall either Party be held responsible for any special, consequential, punitive, incidental, or indirect damages, or losses in profits, arising out of this Agreement, regardless of the cause and regardless of whether such loss was foreseeable. This limitation applies even if a Party has been made aware of the possibility of such damage. However, in the event that a Party is found liable for any breach or default under this Agreement, its liability shall be limited to direct damages only, unless otherwise specified in writing by both Parties.",
    "contradiction_score": 0.008320574648678303,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 153,
    "start_char": 79304,
    "end_char": 79500,
    "original": "b) EXCEPT AS SET FORTH BELOW IN THIS SECTION 13.4(b), IN NO EVENT WILL SUPPLIER\u2019S LIABILITY, [* * *], BE GREATER THAN, PER CLAIM OR SERIES OF CLAIMS ARISING FROM THE SAME CAUSE OF ACTION, [* * *].",
    "ollama_generated": "b) Except as explicitly outlined in this Section 13.4(b), it is expressly agreed that Supplier's total liability, regardless of the nature or form, will not exceed the amount claimed per incident or cumulative series of incidents stemming from the same cause of action, [* * *]. This limitation on liability is fundamental and crucial to the economic balance between the Parties.",
    "contradiction_score": 0.0014555926900357008,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 155,
    "start_char": 79755,
    "end_char": 79960,
    "original": "EXCEPT AS SET FORTH BELOW IN THIS SECTION 13.4(b), WITH RESPECT [* * *], IN NO EVENT SHALL A PARTY\u2019S LIABILITY BE GREATER THAN, PER CLAIM OR SERIES OF CLAIMS ARISING FROM THE SAME CAUSE OF ACTION, [* * *].",
    "ollama_generated": "In all instances not expressly outlined in this Section 13.4(b), with regard to the matters specified, a party's potential liability will be limited, for each claim or accumulation of claims stemming from the same cause of action, to an amount that is reasonable and proportionate, taking into account the nature and extent of the harm suffered and the contractual relationship between the parties.",
    "contradiction_score": 0.07105865329504013,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 157,
    "start_char": 80231,
    "end_char": 81013,
    "original": "[* * *] Article 14 Indemnification 14.1 Indemnification of Supplier Customer shall indemnify, defend and hold harmless Supplier and its officers, directors, agents, servants and employees against any and all actions, claims, demands, proceedings, suits, losses, damages, costs and expenses (including reasonable legal fees) of Third Parties (in this Article 14, \u201cClaims\u201d) (including Claims for personal injury or death) to the extent such Claims result from or arise out of (a) any product liability claim directly related to Customer\u2019s commercial use, sale or distribution of Products or (b) Customer\u2019s [* * *] acts or omissions or [* * *], except, in each case of clause (a) and (b), to the extent Supplier has an obligation to indemnify Customer pursuant to Section 14.2 or 14.3.",
    "ollama_generated": "Article 14 Indemnification\n\n14.1 Obligation of Indemnity\nSupplier agrees to defend, indemnify, and hold harmless Customer, as well as its officers, directors, agents, representatives, and employees, from any and all actions, claims, demands, proceedings, suits, losses, damages, costs, and expenses (including reasonable attorney fees) arising from or related to Third-Party Claims. These claims include those for personal injury or death, provided that such claims are not due to:\n\na) any product liability claim directly associated with Supplier's manufacturing, provision, or delivery of Products, or\nb) the negligence or intentional misconduct of Supplier (excluding gross negligence), except in instances where Customer has a countervailing obligation to be indemnified by Supplier under Sections 14.2 or 14.3.",
    "contradiction_score": 0.018007924780249596,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 158,
    "start_char": 81013,
    "end_char": 81753,
    "original": "14.2 Indemnification of Customer Supplier shall indemnify, defend and hold harmless Customer and its Affiliates and Customer Licensees, and their respective officers, directors, agents, servants, employees and consultants against any and all Claims (including Claims for personal injury or death) to the extent such Claims result from or arise out of (a) any [* * *] acts or omissions or [* * *] by Supplier or its officers, directors, agents, servants, CONFIDENTIAL  Page 33 of 49 Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.",
    "ollama_generated": "14.2 Indemnification of the Supplier shall be responsible for indemnifying, defending, and holding harmless the Customer, its Affiliates, and the Customer's Licensees, as well as their respective officers, directors, agents, employees, and consultants against any and all Claims (including Claims for personal injury or death), to the extent such claims result from or arise out of:\n\n(a) any negligent acts or omissions or willful misconduct by the Customer or its representatives. This provision applies to any claims that may potentially impact the confidential information provided during this agreement, as marked with [* * *] in the original document and filed separately with the Securities and Exchange Commission. The redaction process has been undertaken at the request of confidentiality treatment.",
    "contradiction_score": 0.005490958224982023,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 164,
    "start_char": 85691,
    "end_char": 85912,
    "original": "Article 15 Insurance 15.1 Insurance Coverage Customer and Supplier each represent that they are sufficiently insured against any liability arising under this Agreement. Further, Supplier shall at a minimum retain [* * *].",
    "ollama_generated": "Article 15 Insurance\n15.1 Scope of Insurance Coverage: The parties acknowledge their insurance obligations, with the Customer and Supplier each certifying that they maintain appropriate insurance coverage for any potential liabilities arising from this Agreement. However, the minimum insurance requirements for the Supplier shall be discretionary, at their sole judgement, rather than being prescribed explicitly.\n\nIn this version, the obligation on the supplier to retain a specific level of insurance is shifted from an explicit requirement to a discretionary decision, making it less binding and potentially weaker.",
    "contradiction_score": 0.007358700968325138,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 165,
    "start_char": 85912,
    "end_char": 86603,
    "original": "15.2 Evidence of Insurance Each of Customer and Supplier shall, upon request by the other, provide the other Party with a copy of all insurance policies maintained under this Article 15 relating to the Manufacture of the Product in bulk quantities and the facilities therefor and shall notify the other Party in writing at least 30 days prior to the cancellation of or any material change to such insurance policies. Each Party may request that the other Party procure and maintain such additional insurance coverage relating to the Manufacture of the Product and the facilities therefore as may be reasonably necessary in respect of the Parties\u2019 respective obligations under this Agreement.",
    "ollama_generated": "15.2 Insurance Obligations\nBoth the Customer and Supplier are required, upon reasonable request by either Party, to supply copies of their insurance policies relevant to the Manufacture of the Product in bulk quantities and the associated facilities. This information should be updated at least 30 days prior to any policy cancellations or significant changes. It is important to note that neither Party is obligated to procure additional insurance coverage, but either may request such action from the other if they deem it necessary for fulfilling their respective obligations under this Agreement. However, the decision to obtain and maintain any additional coverage remains at the discretion of each Party.",
    "contradiction_score": 0.10825132578611374,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 168,
    "start_char": 87339,
    "end_char": 87726,
    "original": "b) Customer shall be responsible for obtaining all necessary import and/or export licenses or permits and for the payment of all import and/or export fees, taxes or duties in connection with the purchase and/or delivery of the Product under this Agreement. Supplier shall reasonably cooperate with Customer in connection with obtaining necessary import and/or export licenses or permits.",
    "modified": "a) Supplier shall bear the primary responsibility for securing all required import and/or export licenses or permits, and for the payment of any associated import and/or export fees, taxes, or duties in relation to the purchase and/or delivery of the Product under this Agreement. The Customer agrees to provide reasonable assistance and cooperation in supplying necessary information and documentation as requested by the Supplier for this purpose. In case the Supplier fails to obtain the necessary licenses or permits, the Customer shall have a reasonable timeframe to make alternative arrangements at their own expense and risk.",
    "contradiction_score": 0.9847662448883057,
    "kept": true
  },
  {
    "clause_index": 175,
    "start_char": 90730,
    "end_char": 91020,
    "original": "Supplier shall make available to Customer all relevant records and reports and Customer shall have the right to copy all Product related records and reports. The frequency of such audits as well as the response time with respect to audit findings shall be governed by the Quality Agreement.",
    "ollama_generated": "Supplier is obligated to provide Customer access to all pertinent records and reports, though the Customer's right to reproduce these documents is contingent upon obtaining written consent from the Supplier in advance. The timing and frequency of audits, along with the Supplier's response time regarding audit findings, will be regulated by the terms specified within the Quality Agreement. This arrangement implies that the Customer's access to copies may be subject to certain conditions or limitations as defined in the Quality Agreement.",
    "contradiction_score": 0.0027108932845294476,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 180,
    "start_char": 92584,
    "end_char": 92592,
    "original": "[* * *].",
    "ollama_generated": "[Participant acknowledges and agrees that any potential risks, losses, liabilities, claims, actions, damages, or expenses arising from or in connection with the Event are solely the responsibility of Participant.]\n\nAlternative Rewritten Clause:\n[The Organizer will not be held responsible for any potential risks, losses, liabilities, claims, actions, damages, or expenses that may arise to the Participant as a result of or in connection with the Event.]",
    "contradiction_score": 0.2761422395706177,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 181,
    "start_char": 92593,
    "end_char": 92692,
    "original": "Such liability shall not limit or otherwise be exclusive of any other provisions of this Agreement.",
    "ollama_generated": "This provision does not exclude or serve to limit any other obligations or stipulations set forth in this Agreement. Instead, it is intended to coexist and complement the remaining terms herein.",
    "contradiction_score": 0.0015877780970185995,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 190,
    "start_char": 96326,
    "end_char": 96440,
    "original": "18.2 Consequences of Termination On expiration or the effective date of termination of this Agreement, if earlier:",
    "modified": "18.2 Implications of Expiration or Termination: Upon the natural expiry or the chosen termination date of this Agreement, whichever occurs first:\n\nThis revision softens the language slightly by using \"implications\" instead of \"consequences,\" and rephrases the order of events to emphasize the choice in termination.",
    "contradiction_score": 0.676771342754364,
    "kept": true
  },
  {
    "clause_index": 201,
    "start_char": 103331,
    "end_char": 103979,
    "original": "Customer shall be entitled to assign this Agreement, in whole or in part, to any person without the consent of Supplier, provided that (i) such person acquires all, or substantially all, of Customer\u2019s business or assets with respect to the Product, whether through merger or otherwise\u037e (ii) such person is an Affiliate of Customer or a Customer Licensee\u037e or (iii) Customer remains liable for any payments Supplier is or will be entitled to under this Agreement. Customer shall not assign this Agreement, in whole or in part, to any other person without the prior written consent of Supplier, not to be unreasonably withheld, conditioned or delayed.",
    "ollama_generated": "Assigning this Agreement, either wholly or partially, lies within the discretion of the Assignee (potential new Customer), who may do so without seeking Supplier's consent, except in instances where:\n\n(i) The Assignee does not acquire all or substantially all of Customer's business or assets related to the Product; or\n\n(ii) The Assignee is neither an Affiliate of the Customer nor a Customer Licensee; or\n\n(iii) The Customer does not remain liable for any payments Supplier may become entitled to under this Agreement.\n\nHowever, in cases where the Assignee does not meet the criteria outlined above, their request for assignment requires the prior written approval of Supplier, which shall not be arbitrarily withheld, conditioned, or delayed.",
    "contradiction_score": 0.20067596435546875,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 206,
    "start_char": 107029,
    "end_char": 107439,
    "original": "19.6 Performance Each Party agrees to perform its obligations under this Agreement, including under any Scope of Work, in a timely manner. Supplier shall allocate adequate resources to execute its obligations under this Agreement, including under each Scope of Work. Supplier represents and warrants that all Services shall be performed by qualified personnel in accordance with the highest industry standards.",
    "ollama_generated": "19.6 Performance Each Party acknowledges its commitment to fulfilling their respective responsibilities as outlined within this Agreement, encompassing any attached Scope of Work. The Responsible Party assumes responsibility for ensuring appropriate resources are available to meet these obligations. While every effort will be made to adhere to industry standards and best practices, the Responsible Party does not guarantee the performance of Services by personnel possessing specialized qualifications.\n\nChanges made:\n- Weakened the obligation slightly by shifting the onus of allocating resources to the party responsible for fulfilling its obligations (Responsible Party).\n- Changed the representation and warranty from a guarantee that services will be performed by qualified personnel to an acknowledgment that every effort will be made to adhere to industry standards, but qualifications are not guaranteed.",
    "contradiction_score": 0.08801238983869553,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 212,
    "start_char": 108905,
    "end_char": 109684,
    "original": "19.10 Notices Unless otherwise provided herein, any notice required or permitted to be given hereunder or any proposal for any modification of this Agreement (hereinafter collectively referred to as the \u201cCorrespondence\u201d) shall be faxed, mailed by overnight mail, certified mail postage prepaid, or delivered by hand to the Party to whom such Correspondence is required or permitted to be given hereunder at the addresses set out below. If delivered by hand, any such Correspondence shall be deemed to have been given when received by the Party to whom such Correspondence is given and if faxed, any such Correspondence shall be deemed to have been given on the first Business Day following facsimile transmission, as evidenced by written and dated receipt of the receiving Party.",
    "ollama_generated": "19.10 Communications: Except as explicitly stated within this Agreement, all notices or proposals for modification (collectively referred to as \"Communications\") shall be delivered via email, courier, or in person to the designated addresses below. Emailed Communications will be considered as received on the day they are sent, while those delivered by courier or in person will be deemed delivered upon confirmation of receipt from the receiving party. No response is required to acknowledge receipt. If no reply is received within five (5) business days, the sender may resend the Communication or consider it as having been accepted unless otherwise explicitly communicated in writing.\n\nThis revised clause weakens the original by removing the requirement for a written and dated receipt of the receiving party when Communications are delivered by fax. It also relaxes the timeframe for responding to Communications, allowing more flexibility for the recipient. Additionally, it includes a provision for the sender to consider the Communication as accepted if no response is received within five business days unless otherwise communicated in writing, further weakening the obligation of the recipient to respond promptly.",
    "contradiction_score": 0.22018390893936157,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 222,
    "start_char": 112287,
    "end_char": 112438,
    "original": "IN WITNESS WHEREOF, each of the Parties hereto has caused this Agreement to be executed by its duly authorized officer as of the dates set forth below.",
    "ollama_generated": "FOR THE RECORD AND TO ESTABLISH LEGAL OBLIGATION, each of the Parties involved herein authorizes their respective representatives to sign this Agreement on the individual date(s) specified below.",
    "contradiction_score": 0.0013993621105328202,
    "kept": false,
    "reason": "low_contradiction"
  }
]